QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: |
Not Applicable | ||
(Former name, former address and former fiscal year, if changed since last report) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
x | Accelerated filer | ¨ | |||||||||
Non-accelerated filer | ¨ | Smaller reporting company | |||||||||
Emerging growth company |
Class A Common Stock | Shares outstanding as of June 4, 2025 | |||||||
$0.01 Par Value |
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 5. | ||||||||
Item 6. | ||||||||
Abercrombie & Fitch Co. | 2 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||
Net sales | $ | $ | |||||||||
Cost of sales, exclusive of depreciation and amortization | |||||||||||
Selling expense | |||||||||||
General and administrative expense | |||||||||||
Other operating loss (income), net | ( | ||||||||||
Operating income | |||||||||||
Interest expense | |||||||||||
Interest income | ( | ( | |||||||||
Interest income, net | ( | ( | |||||||||
Income before income taxes | |||||||||||
Income tax expense | |||||||||||
Net income | |||||||||||
Less: Net income attributable to noncontrolling interests | |||||||||||
Net income attributable to A&F | $ | $ | |||||||||
Net income per share attributable to A&F | |||||||||||
Basic | $ | $ | |||||||||
Diluted | $ | $ | |||||||||
Weighted-average shares outstanding | |||||||||||
Basic | |||||||||||
Diluted | |||||||||||
Other comprehensive loss | |||||||||||
Foreign currency translation adjustments, net of tax | $ | $ | ( | ||||||||
Derivative financial instruments, net of tax | ( | ||||||||||
Other comprehensive loss | ( | ( | |||||||||
Comprehensive income | |||||||||||
Less: Comprehensive income attributable to noncontrolling interests | |||||||||||
Comprehensive income attributable to A&F | $ | $ | |||||||||
Abercrombie & Fitch Co. | 3 | 2025 1Q Form 10-Q |
May 3, 2025 | February 1, 2025 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and equivalents | $ | $ | |||||||||
Marketable securities | |||||||||||
Receivables | |||||||||||
Inventories | |||||||||||
Other current assets | |||||||||||
Total current assets | |||||||||||
Property and equipment, net | |||||||||||
Operating lease right-of-use assets | |||||||||||
Other assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities and stockholders’ equity | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | $ | |||||||||
Accrued expenses | |||||||||||
Short-term portion of operating lease liabilities | |||||||||||
Income taxes payable | |||||||||||
Total current liabilities | |||||||||||
Long-term liabilities: | |||||||||||
Long-term portion of operating lease liabilities | |||||||||||
Other liabilities | |||||||||||
Total long-term liabilities | |||||||||||
Stockholders’ equity | |||||||||||
Class A Common Stock: $ | |||||||||||
Paid-in capital | |||||||||||
Retained earnings | |||||||||||
Accumulated other comprehensive loss, net of tax (“AOCL”) | ( | ( | |||||||||
Treasury stock, at average cost: | ( | ( | |||||||||
Total Abercrombie & Fitch Co. stockholders’ equity | |||||||||||
Noncontrolling interests | |||||||||||
Total stockholders’ equity | |||||||||||
Total liabilities and stockholders’ equity | $ | $ |
Abercrombie & Fitch Co. | 4 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended May 3, 2025 | |||||||||||||||||||||||||||||
Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity | |||||||||||||||||||||||
Shares outstanding | Par value | Shares | At average cost | ||||||||||||||||||||||||||
Balance, February 1, 2025 | $ | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||
Net income | — | — | — | — | — | — | |||||||||||||||||||||||
Purchase of Common Stock(1) | ( | — | — | — | — | — | ( | ( | |||||||||||||||||||||
Share-based compensation issuances and exercises | — | ( | — | ( | — | ( | ( | ||||||||||||||||||||||
Share-based compensation expense | — | — | — | — | — | — | — | ||||||||||||||||||||||
Derivative financial instruments, net of tax | — | — | — | — | — | ( | — | — | ( | ||||||||||||||||||||
Foreign currency translation adjustments, net of tax | — | — | — | — | — | — | — | ||||||||||||||||||||||
Distribution to noncontrolling interests, net | — | — | — | ( | — | — | — | — | ( | ||||||||||||||||||||
Ending balance at May 3, 2025 | $ | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||
Thirteen Weeks Ended May 4, 2024 | |||||||||||||||||||||||||||||
Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity | |||||||||||||||||||||||
Shares outstanding | Par value | Shares | At average cost | ||||||||||||||||||||||||||
Balance, February 3, 2024 | $ | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||
Net income | — | — | — | — | — | — | |||||||||||||||||||||||
Purchase of Common Stock | ( | — | — | — | — | — | ( | ( | |||||||||||||||||||||
Share-based compensation issuances and exercises | — | ( | — | ( | — | ( | ( | ( | |||||||||||||||||||||
Share-based compensation expense | — | — | — | — | — | — | — | ||||||||||||||||||||||
Derivative financial instruments, net of tax | — | — | — | — | — | — | — | ||||||||||||||||||||||
Foreign currency translation adjustments, net of tax | — | — | — | — | — | ( | — | — | ( | ||||||||||||||||||||
Distribution to noncontrolling interests, net | — | — | — | ( | — | — | — | — | ( | ||||||||||||||||||||
Ending balance at May 4, 2024 | $ | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||
(1)Includes commissions and excise tax on share repurchases |
Abercrombie & Fitch Co. | 5 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||
Operating activities | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash (used for) provided by operating activities: | |||||||||||
Depreciation and amortization | |||||||||||
Amortization of capitalized cloud computing arrangement implementation costs | |||||||||||
Asset impairment | |||||||||||
Loss on disposal | |||||||||||
Provision for deferred income taxes | |||||||||||
Share-based compensation | |||||||||||
Loss on extinguishment of debt | |||||||||||
Changes in assets and liabilities: | |||||||||||
Inventories | |||||||||||
Accounts payable and accrued expenses | ( | ( | |||||||||
Operating lease right-of-use assets and liabilities | ( | ||||||||||
Income taxes | |||||||||||
Other assets | ( | ( | |||||||||
Other liabilities | ( | ||||||||||
Net cash (used for) provided by operating activities | ( | ||||||||||
Investing activities | |||||||||||
Proceeds from maturities of marketable securities | |||||||||||
Purchases of property and equipment | ( | ( | |||||||||
Net cash used for investing activities | ( | ( | |||||||||
Financing activities | |||||||||||
Repayment/redemption of senior secured notes | ( | ||||||||||
Purchases of Common Stock | ( | ( | |||||||||
Acquisition of Common Stock for tax withholding obligations | ( | ( | |||||||||
Other financing activities | ( | ( | |||||||||
Net cash used for financing activities | ( | ( | |||||||||
Effect of foreign currency exchange rates on cash | ( | ||||||||||
Net decrease in cash and equivalents, and restricted cash and equivalents | ( | ( | |||||||||
Cash and equivalents, and restricted cash and equivalents, beginning of period | |||||||||||
Cash and equivalents, and restricted cash and equivalents, end of period | $ | $ | |||||||||
Supplemental information related to non-cash activities | |||||||||||
Purchases of property and equipment accrued in accounts payable | $ | $ | |||||||||
Excise tax liability accrued on share repurchases | |||||||||||
Operating lease right-of-use assets additions, net of terminations, impairments and other reductions | |||||||||||
Supplemental information related to cash activities | |||||||||||
Cash paid for interest | |||||||||||
Cash paid for income taxes | |||||||||||
Cash received from income tax refunds | |||||||||||
Cash paid for amounts included in measurement of operating lease liabilities |
Abercrombie & Fitch Co. | 6 | 2025 1Q Form 10-Q |
Page No. | ||||||||
Note 1. | ||||||||
Note 2. | ||||||||
Note 3. | ||||||||
Note 4. | ||||||||
Note 5. | ||||||||
Note 6. | ||||||||
Note 7. | ||||||||
Note 8. | ||||||||
Note 9. | ||||||||
Note 10. | ||||||||
Note 11. | ||||||||
Note 12. | ||||||||
Note 13. | ||||||||
Note 14. | ||||||||
Abercrombie & Fitch Co. | 7 | 2025 1Q Form 10-Q |
Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
Fiscal 2024 | February 1, 2025 | 52 | ||||||||||||
Fiscal 2025 | January 31, 2026 | 52 | ||||||||||||
Fiscal 2026 | January 30, 2027 | 52 |
Abercrombie & Fitch Co. | 8 | 2025 1Q Form 10-Q |
Accounting Standards Update (ASU) | Description | Effect on the financial statements or other significant matters | ||||||||||||
ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures | The update requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The update is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. | Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements. | ||||||||||||
ASU 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ASU 2025-01 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date | The update requires a disaggregated disclosure of income statement expenses. The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The update is effective for fiscal years beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. | Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements. |
(in thousands) | Location | May 3, 2025 | February 1, 2025 | May 4, 2024 | February 3, 2024 | ||||||||||||||||||||||||
Cash and equivalents | Cash and equivalents | $ | $ | $ | $ | ||||||||||||||||||||||||
Restricted cash and equivalents | Other assets | ||||||||||||||||||||||||||||
Cash and equivalents and restricted cash and equivalents | $ | $ | $ | $ |
Abercrombie & Fitch Co. | 9 | 2025 1Q Form 10-Q |
(in thousands) | May 3, 2025 | February 1, 2025 | May 4, 2024 | February 3, 2024 | |||||||||||||||||||
Gift card liability (1) | $ | $ | $ | $ | |||||||||||||||||||
Loyalty programs liability |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Revenue associated with gift card redemptions and gift card breakage | $ | $ | |||||||||
Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs |
Abercrombie & Fitch Co. | 10 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Shares of Common Stock issued | |||||||||||
Weighted-average treasury shares | ( | ( | |||||||||
Weighted-average — basic shares | |||||||||||
Dilutive effect of share-based compensation awards | |||||||||||
Weighted-average — diluted shares | |||||||||||
Anti-dilutive shares (1) |
Assets and Liabilities at Fair Value as of May 3, 2025 | |||||||||||||||||||||||
(in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents (1) | $ | $ | $ | $ | |||||||||||||||||||
Derivative instruments (2) | |||||||||||||||||||||||
Rabbi Trust assets (3) | |||||||||||||||||||||||
Restricted cash equivalents (1) | |||||||||||||||||||||||
Total assets | $ | $ | $ | $ | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Derivative instruments (2) | $ | $ | $ | $ | |||||||||||||||||||
Total liabilities | $ | $ | $ | $ |
Assets and Liabilities at Fair Value as of February 1, 2025 | |||||||||||||||||||||||
(in thousands) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents (1) | $ | $ | $ | $ | |||||||||||||||||||
Derivative instruments (2) | |||||||||||||||||||||||
Rabbi Trust assets (3) | |||||||||||||||||||||||
Restricted cash equivalents (1) | |||||||||||||||||||||||
Total assets | $ | $ | $ | $ | |||||||||||||||||||
Abercrombie & Fitch Co. | 11 | 2025 1Q Form 10-Q |
(in thousands) | May 3, 2025 | February 1, 2025 | |||||||||
Property and equipment, at cost | $ | $ | |||||||||
Less: Accumulated depreciation and amortization | ( | ( | |||||||||
Property and equipment, net | $ | $ |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Single lease cost (1) | $ | $ | |||||||||
Variable lease cost (2) | |||||||||||
Operating lease right-of-use asset impairment (3) | |||||||||||
Sublease income | ( | ( | |||||||||
Total operating lease cost | $ | $ |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Operating lease right-of-use asset impairment | $ | $ | |||||||||
Property and equipment asset impairment | |||||||||||
Total asset impairment | $ | $ |
Abercrombie & Fitch Co. | 12 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 13 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Share-based compensation expense | $ | $ | |||||||||
Income tax benefits associated with share-based compensation expense recognized |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Income tax discrete benefits realized for tax deductions related to the issuance of shares | $ | $ | |||||||||
Income tax discrete charges realized upon cancellation of stock appreciation rights | |||||||||||
Total income tax discrete benefits related to share-based compensation awards | $ | $ |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Employee tax withheld upon issuance of shares (1) | $ | $ |
Service-based Restricted Stock Units | Performance-based Restricted Stock Units | Market-based Restricted Stock Units | |||||||||||||||||||||||||||||||||
Number of Underlying Shares | Weighted- Average Grant Date Fair Value | Number of Underlying Shares | Weighted- Average Grant Date Fair Value | Number of Underlying Shares | Weighted- Average Grant Date Fair Value | ||||||||||||||||||||||||||||||
Unvested at February 1, 2025 | $ | $ | $ | ||||||||||||||||||||||||||||||||
Granted | |||||||||||||||||||||||||||||||||||
Adjustments for performance achievement | |||||||||||||||||||||||||||||||||||
Vested | ( | ( | ( | ||||||||||||||||||||||||||||||||
Forfeited | ( | ||||||||||||||||||||||||||||||||||
Unvested at May 3, 2025 (1) | $ | $ | $ |
Service-based Restricted Stock Units | Performance-based Restricted Stock Units | Market-based Restricted Stock Units | |||||||||||||||
Unrecognized compensation cost (in thousands) | $ | $ | $ | ||||||||||||||
Remaining weighted-average period cost is expected to be recognized (years) |
Abercrombie & Fitch Co. | 14 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Service-based restricted stock units: | |||||||||||
Total grant date fair value of awards granted | $ | $ | |||||||||
Total grant date fair value of awards vested | |||||||||||
Performance-based restricted stock units: | |||||||||||
Total grant date fair value of awards granted | |||||||||||
Total grant date fair value of awards vested | |||||||||||
Market-based restricted stock units: | |||||||||||
Total grant date fair value of awards granted | |||||||||||
Total grant date fair value of awards vested |
Thirteen Weeks Ended | |||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||
Grant date market price | $ | $ | |||||||||
Fair value | |||||||||||
Price volatility | % | % | |||||||||
Expected term (years) | |||||||||||
Risk-free interest rate | % | % | |||||||||
Dividend yield | |||||||||||
Average volatility of peer companies | |||||||||||
Average correlation coefficient of peer companies |
Abercrombie & Fitch Co. | 15 | 2025 1Q Form 10-Q |
(in thousands) | Notional Amount (1) | ||||
Euro | $ | ||||
British pound | |||||
Canadian dollar | |||||
(in thousands) | Location | May 3, 2025 | February 1, 2025 | Location | May 3, 2025 | February 1, 2025 | |||||||||||||||||||||||||||||
Derivatives designated as cash flow hedging instruments | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Derivatives not designated as hedging instruments | |||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
(Loss) gain recognized in AOCL (1) | $ | ( | $ | ||||||||
Gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Gain recognized in other operating loss (income), net | $ | $ |
Abercrombie & Fitch Co. | 16 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended May 3, 2025 | |||||||||||||||||
(in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
Beginning balance at February 1, 2025 | $ | ( | $ | $ | ( | ||||||||||||
Other comprehensive income (loss) before reclassifications | ( | ( | |||||||||||||||
Reclassified gain from AOCL (1) | ( | ( | |||||||||||||||
Tax effect | |||||||||||||||||
Other comprehensive income (loss) after reclassifications | ( | ( | |||||||||||||||
Ending balance at May 3, 2025 | $ | ( | $ | ( | $ | ( | |||||||||||
Thirteen Weeks Ended May 4, 2024 | |||||||||||||||||
(in thousands) | Foreign Currency Translation Adjustment | Unrealized Gain (Loss) on Derivative Financial Instruments | Total | ||||||||||||||
Beginning balance at February 3, 2024 | $ | ( | $ | $ | ( | ||||||||||||
Other comprehensive (loss) income before reclassifications | ( | ( | |||||||||||||||
Reclassified gain from AOCL (1) | ( | ( | |||||||||||||||
Tax effect | ( | ( | |||||||||||||||
Other comprehensive (loss) income after reclassifications | ( | ( | |||||||||||||||
Ending balance at May 4, 2024 | $ | ( | $ | $ | ( | ||||||||||||
Abercrombie & Fitch Co. | 17 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended May 3, 2025 | |||||||||||||||||||||||
(in thousands) | Americas (1) | EMEA | APAC | Total | |||||||||||||||||||
Net sales | $ | $ | $ | $ | |||||||||||||||||||
Cost of sales, exclusive of depreciation and amortization | |||||||||||||||||||||||
Store occupancy (2) | |||||||||||||||||||||||
Fulfillment (2) | |||||||||||||||||||||||
Other expense (3) | |||||||||||||||||||||||
Segment income (loss) | $ | $ | $ | ( | $ | ||||||||||||||||||
Operating loss not attributed to segments: | |||||||||||||||||||||||
Corporate and other unallocated expenses (4) | ( | ||||||||||||||||||||||
Operating income | $ | ||||||||||||||||||||||
Interest income, net | ( | ||||||||||||||||||||||
Income before income taxes | $ | ||||||||||||||||||||||
Depreciation and amortization | $ | $ | $ | $ | |||||||||||||||||||
Depreciation and amortization not attributed to segments | |||||||||||||||||||||||
Total depreciation and amortization | $ | ||||||||||||||||||||||
Capital expenditures | $ | $ | $ | $ | |||||||||||||||||||
Capital expenditures not attributed to segments | |||||||||||||||||||||||
Total capital expenditures | $ |
Thirteen Weeks Ended May 4, 2024 | |||||||||||||||||||||||
(in thousands) | Americas (1) | EMEA | APAC | Total | |||||||||||||||||||
Net sales | $ | $ | $ | $ | |||||||||||||||||||
Cost of sales, exclusive of depreciation and amortization | |||||||||||||||||||||||
Store occupancy (2) | |||||||||||||||||||||||
Fulfillment (2) | |||||||||||||||||||||||
Other expense (3) | |||||||||||||||||||||||
Segment income (loss) | $ | $ | $ | ( | $ | ||||||||||||||||||
Operating loss not attributed to segments: | |||||||||||||||||||||||
Corporate and other unallocated expenses (4) | ( | ||||||||||||||||||||||
Operating income | $ | ||||||||||||||||||||||
Interest income, net | ( | ||||||||||||||||||||||
Income before income taxes | $ | ||||||||||||||||||||||
Depreciation and amortization | $ | $ | $ | $ | |||||||||||||||||||
Depreciation and amortization not attributed to segments | |||||||||||||||||||||||
Total depreciation and amortization | $ | ||||||||||||||||||||||
Capital expenditures | $ | $ | $ | $ | |||||||||||||||||||
Capital expenditures not attributed to segments | |||||||||||||||||||||||
Total capital expenditures | $ |
Abercrombie & Fitch Co. | 18 | 2025 1Q Form 10-Q |
Assets | |||||||||||||||||
(in thousands) | May 3, 2025 | February 1, 2025 | May 4, 2024 | ||||||||||||||
Inventories | |||||||||||||||||
Americas | $ | $ | $ | ||||||||||||||
EMEA | |||||||||||||||||
APAC | |||||||||||||||||
Total inventories | $ | $ | $ | ||||||||||||||
Assets not attributed to segments | |||||||||||||||||
Total assets | $ | $ | $ |
(in thousands) | May 3, 2025 | February 1, 2025 | May 4, 2024 | ||||||||||||||
Americas (1) (2) | $ | $ | $ | ||||||||||||||
EMEA (3) | |||||||||||||||||
APAC | |||||||||||||||||
Total | $ | $ | $ |
Thirteen Weeks Ended | |||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | |||||||||
Abercrombie | $ | $ | |||||||||
Hollister | |||||||||||
Total | $ | $ |
Abercrombie & Fitch Co. | 19 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 20 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 21 | 2025 1Q Form 10-Q |
Fiscal year | Year ended/ending | Number of weeks | ||||||||||||
Fiscal 2024 | February 1, 2025 | 52 | ||||||||||||
Fiscal 2025 | January 31, 2026 | 52 | ||||||||||||
Fiscal 2026 | January 30, 2027 | 52 |
Abercrombie & Fitch Co. | 22 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 23 | 2025 1Q Form 10-Q |
GAAP | Non-GAAP (1) | |||||||||||||||||||||||||
Thirteen Weeks Ended | May 3, 2025 | May 4, 2024 | May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||
Net sales (in thousands) | $ | 1,097,311 | $ | 1,020,730 | ||||||||||||||||||||||
Change in net sales | 7.5 | % | 22.1 | % | ||||||||||||||||||||||
Comparable sales (2) | 4 | % | 21 | % | ||||||||||||||||||||||
Operating income (in thousands) | $ | 101,533 | $ | 129,849 | ||||||||||||||||||||||
Operating income margin | 9.3 | % | 12.7 | % | ||||||||||||||||||||||
Net income attributable to A&F (in thousands) | $ | 80,413 | $ | 113,850 | ||||||||||||||||||||||
Net income per share attributable to A&F | $ | 1.59 | $ | 2.14 | ||||||||||||||||||||||
(in thousands) | May 3, 2025 | February 1, 2025 | ||||||||||||
Cash and equivalents | $ | 510,563 | $ | 772,727 | ||||||||||
Marketable securities | 97,006 | 116,221 | ||||||||||||
Inventories | 542,059 | 575,005 | ||||||||||||
(in thousands) | May 3, 2025 | May 4, 2024 | ||||||||||||
Net cash (used for) provided by operating activities | $ | (4,000) | $ | 95,010 | ||||||||||
Net cash used for investing activities | (30,764) | (38,886) | ||||||||||||
Net cash used for financing activities | (234,513) | (92,951) |
Abercrombie & Fitch Co. | 24 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
(in thousands, except ratios) | May 3, 2025 | May 4, 2024 | $ Change | % Change | Comparable Sales (1) | ||||||||||||||||||||||||
By segment: | |||||||||||||||||||||||||||||
Americas | $ | 874,804 | $ | 820,121 | $ | 54,683 | 7 | % | 4 | % | |||||||||||||||||||
EMEA | 185,036 | 164,778 | 20,258 | 12 | 6 | ||||||||||||||||||||||||
APAC | 37,471 | 35,831 | 1,640 | 5 | 2 | ||||||||||||||||||||||||
Total | $ | 1,097,311 | $ | 1,020,730 | $ | 76,581 | 8 | 4 | |||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
(in thousands, except ratios) | May 3, 2025 | May 4, 2024 | $ Change | % Change | Comparable Sales (1) | ||||||||||||||||||||||||
Abercrombie | $ | 547,947 | $ | 571,513 | $ | (23,566) | (4) | % | (10) | % | |||||||||||||||||||
Hollister | 549,364 | 449,217 | 100,147 | 22 | 23 | ||||||||||||||||||||||||
Total | $ | 1,097,311 | $ | 1,020,730 | $ | 76,581 | 8 | 4 | |||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Cost of sales, exclusive of depreciation and amortization | $ | 417,133 | 38.0 | % | $ | 343,273 | 33.6 | % | 440 | ||||||||||||||||||||
Abercrombie & Fitch Co. | 25 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Selling expense | $ | 399,937 | 36.4 | % | $ | 360,018 | 35.3 | % | 110 | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
General and administrative expense | $ | 174,925 | 15.9 | % | $ | 189,548 | 18.6 | % | (270) | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Other operating loss (income), net | $ | 3,783 | 0.3 | % | $ | (1,958) | (0.2) | % | 50 | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales(1) | % of Net sales(1) | BPS Change | ||||||||||||||||||||||||||
Americas | $ | 226,960 | 25.9 | % | $ | 252,347 | 30.8 | % | (490) | ||||||||||||||||||||
EMEA | 16,034 | 8.7 | 24,501 | 14.9 | (620) | ||||||||||||||||||||||||
APAC | (4,410) | (11.8) | (322) | (0.9) | (1,090) | ||||||||||||||||||||||||
Operating loss not attributed to segments | (137,051) | (146,677) | |||||||||||||||||||||||||||
Operating income | $ | 101,533 | 9.3 | $ | 129,849 | 12.7 | (340) | ||||||||||||||||||||||
Abercrombie & Fitch Co. | 26 | 2025 1Q Form 10-Q |
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Interest expense | $ | 661 | 0.1 | % | $ | 5,780 | 0.6 | % | (50) | ||||||||||||||||||||
Interest income | (7,444) | (0.7) | (10,803) | (1.1) | 40 | ||||||||||||||||||||||||
Interest income, net | $ | (6,783) | (0.6) | $ | (5,023) | (0.5) | (10) | ||||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||
(in thousands, except ratios) | Effective Tax Rate | Effective Tax Rate | |||||||||||||||||||||
Income tax expense | $ | 26,577 | 24.5 | % | $ | 19,794 | 14.7 | % | |||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Net income attributable to A&F | $ | 80,413 | 7.3 | % | $ | 113,850 | 11.2 | % | (390) | ||||||||||||||||||||
Thirteen Weeks Ended | |||||||||||||||||
May 3, 2025 | May 4, 2024 | $ Change | |||||||||||||||
Net income per diluted share attributable to A&F | $ | 1.59 | $ | 2.14 | $ | (0.55) | |||||||||||
Impact from changes in foreign currency exchange rates | — | (0.08) | 0.08 | ||||||||||||||
Adjusted non-GAAP net income per diluted share attributable to A&F on a constant currency basis (1) | $ | 1.59 | $ | 2.06 | $ | (0.47) | |||||||||||
Thirteen Weeks Ended | |||||||||||||||||||||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||||||||||||||||||||
(in thousands, except ratios) | % of Net sales | % of Net sales | BPS Change | ||||||||||||||||||||||||||
Net income | $ | 81,739 | 7.4 | % | $ | 115,078 | 11.3 | % | (390) | ||||||||||||||||||||
Income tax expense | 26,577 | 2.4 | 19,794 | 1.9 | 50 | ||||||||||||||||||||||||
Interest (income) expense, net | (6,783) | (0.6) | (5,023) | (0.5) | (10) | ||||||||||||||||||||||||
Depreciation and amortization | 38,576 | 3.6 | 37,689 | 3.7 | (10) | ||||||||||||||||||||||||
EBITDA (1) | $ | 140,109 | 12.8 | $ | 167,538 | 16.4 | (360) | ||||||||||||||||||||||
Abercrombie & Fitch Co. | 27 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 28 | 2025 1Q Form 10-Q |
(in thousands) | May 3, 2025 | ||||
Loan cap | $ | 477,358 | |||
Less: Outstanding stand-by letters of credit | (415) | ||||
Borrowing capacity | 476,943 | ||||
Less: Minimum excess availability (1) | (47,736) | ||||
Borrowing capacity available | $ | 429,207 |
Thirteen Weeks Ended | |||||||||||
May 3, 2025 | May 4, 2024 | ||||||||||
(in thousands) | |||||||||||
Cash and equivalents, and restricted cash and equivalents, beginning of period | $ | 780,395 | $ | 909,685 | |||||||
Net cash (used for) provided by operating activities | (4,000) | 95,010 | |||||||||
Net cash used for investing activities | (30,764) | (38,886) | |||||||||
Net cash used for financing activities | (234,513) | (92,951) | |||||||||
Effect of foreign currency exchange rates on cash | 7,407 | (857) | |||||||||
Net decrease in cash and equivalents, and restricted cash and equivalents | (261,870) | (37,684) | |||||||||
Cash and equivalents, and restricted cash and equivalents, end of period | $ | 518,525 | $ | 872,001 |
Abercrombie & Fitch Co. | 29 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 30 | 2025 1Q Form 10-Q |
(in thousands, except change in net sales, operating income margin and per share data) | Thirteen Weeks Ended | ||||||||||||||||
Net sales | May 3, 2025 | May 4, 2024 | % Change | ||||||||||||||
GAAP | $ | 1,097,311 | $ | 1,020,730 | 8 | % | |||||||||||
Impact from changes in foreign currency exchange rates | — | (208) | — | ||||||||||||||
Non-GAAP on a constant currency basis | $ | 1,097,311 | $ | 1,020,522 | 8 | % | |||||||||||
Operating income | May 3, 2025 | May 4, 2024 | BPS Change (1) | ||||||||||||||
GAAP | $ | 101,533 | $ | 129,849 | (340) | ||||||||||||
Impact from changes in foreign currency exchange rates | — | (5,234) | 50 | ||||||||||||||
Adjusted non-GAAP on a constant currency basis | $ | 101,533 | $ | 124,615 | (290) | ||||||||||||
Net income per share attributable to A&F | May 3, 2025 | May 4, 2024 | $ Change | ||||||||||||||
GAAP | $ | 1.59 | $ | 2.14 | $ | (0.55) | |||||||||||
Impact from changes in foreign currency exchange rates | — | (0.08) | 0.08 | ||||||||||||||
Adjusted non-GAAP on a constant currency basis | $ | 1.59 | $ | 2.06 | $ | (0.47) |
Thirteen Weeks Ended | ||||||||||||||||||||
(in thousands, except ratios) | May 3, 2025 | % of Net Sales | May 4, 2024 | % of Net Sales | ||||||||||||||||
Net income | $ | 81,739 | 7.4 | % | $ | 115,078 | 11.3 | % | ||||||||||||
Income tax expense | 26,577 | 2.4 | 19,794 | 1.9 | ||||||||||||||||
Interest income, net | (6,783) | (0.6) | (5,023) | (0.5) | ||||||||||||||||
Depreciation and amortization | 38,576 | 3.6 | 37,689 | 3.7 | ||||||||||||||||
EBITDA (1) | $ | 140,109 | 12.8 | $ | 167,538 | 16.4 | ||||||||||||||
Abercrombie & Fitch Co. | 31 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 32 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | 33 | 2025 1Q Form 10-Q |
Period (fiscal month) | Total Number of Shares Purchased (1) | Average Price Paid per Share(4) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)(3)(4) | |||||||||||||||||||
February 2, 2025 through March 1, 2025 | — | $ | — | — | $ | 1,300,000,000 | |||||||||||||||||
March 2, 2025 through April 5, 2025 | 1,841,655 | 81.35 | 1,646,251 | 1,184,113,690 | |||||||||||||||||||
April 6, 2025 through May 3, 2025 | 1,239,667 | 67.92 | 1,003,145 | 1,100,039,825 | |||||||||||||||||||
Total | 3,081,322 | 75.95 | 2,649,396 | 1,100,039,825 |
Abercrombie & Fitch Co. | 34 | 2025 1Q Form 10-Q |
Exhibit | Document | |||||||
3.1 | ||||||||
3.2 | ||||||||
31.1 | ||||||||
31.2 | ||||||||
32.1 | ||||||||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded within the Inline XBRL document.* | |||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).* |
Abercrombie & Fitch Co. | 35 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | ||||||||
Date: June 6, 2025 | By: | /s/ Robert J. Ball | ||||||
Robert J. Ball | ||||||||
Senior Vice President, Chief Financial Officer (Principal Financial Officer and Authorized Officer) | ||||||||
By: | /s/ Joseph Frericks | |||||||
Joseph Frericks | ||||||||
Senior Vice President, Corporate Controller (Principal Accounting Officer) |
Abercrombie & Fitch Co. | 36 | 2025 1Q Form 10-Q |
Abercrombie & Fitch Co. | ||||||||
Date: June 6, 2025 | By: | /s/ Fran Horowitz | ||||||
Fran Horowitz | ||||||||
Chief Executive Officer | ||||||||
(Principal Executive Officer) |
Abercrombie & Fitch Co. | ||||||||
Date: June 6, 2025 | By: | /s/ Robert J. Ball | ||||||
Robert J. Ball | ||||||||
Senior Vice President, Chief Financial Officer | ||||||||
(Principal Financial Officer) |
/s/ Fran Horowitz | /s/ Robert J. Ball | |||||||
Fran Horowitz Chief Executive Officer (Principal Executive Officer) | Robert J. Ball Senior Vice President, Chief Financial Officer (Principal Financial Officer) | |||||||
Date: June 6, 2025 | Date: June 6, 2025 |
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - Class A Common Stock - $ / shares shares in Thousands |
May 03, 2025 |
Feb. 01, 2025 |
---|---|---|
Stockholders’ equity | ||
Class A Common Stock, par value | $ 0.01 | $ 0.01 |
Class A Common Stock, shares authorized | 150,000 | 150,000 |
Class A Common Stock, shares issued | 103,300 | 103,300 |
Nature of Business (Notes) |
3 Months Ended |
---|---|
May 03, 2025 | |
Nature of Business [Abstract] | |
Nature of Business | NATURE OF BUSINESS Abercrombie & Fitch Co. (“A&F”), a company incorporated in Delaware in 1996, through its subsidiaries (collectively, A&F and its subsidiaries are referred to as the “Company”), is a global, digitally-led omnichannel retailer. The Company offers a broad assortment of apparel, personal care products and accessories for men, women and kids, which are sold primarily through its Company-owned stores and digital channels, as well as through various third-party arrangements. The Company manages its business on a geographic basis, consisting of three reportable segments: Americas; Europe, the Middle East and Africa (“EMEA”); and Asia-Pacific (“APAC”). Corporate functions and other income and expenses are evaluated on a consolidated basis and are not allocated to the Company’s segments, and therefore are included as a reconciling item between segment and total operating income. The Company’s brands include Abercrombie brands and Hollister brands. These brands share a commitment to offering unique products of enduring quality and exceptional comfort that allow customers around the world to express their own individuality and style.
|
Summary of Significant Accounting Policies |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant Accounting Policies [Text Block] | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in Emirati and Kuwaiti business ventures with Majid al Futtaim Lifestyle L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of the business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive Income and the NCI portion of stockholders’ equity presented as NCI on the Condensed Consolidated Balance Sheets. Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows:
Interim financial statements The Condensed Consolidated Financial Statements as of May 3, 2025, and for the thirteen week periods ended May 3, 2025 and May 4, 2024, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2024 filed with the SEC on March 31, 2025 (the “Fiscal 2024 Form 10-K”). The February 1, 2025 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the U.S. (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2025. Use of estimates The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. Due to the inherent uncertainty involved with estimates, actual results may differ. Additionally, these estimates and assumptions may change as a result of the impact of global economic conditions such as the uncertainty regarding a slowing economy, volatility in interest rates, continued inflation, fluctuation in foreign exchange rates, the imposition of, and changes to, tariffs by the U.S. government and certain trading partners, and geopolitical concerns, all of which could result in material impacts to the Company’s consolidated financial statements in future reporting periods. Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. The following table provides a brief description of certain accounting pronouncements the Company has not yet adopted and that could affect the Company’s financial statements.
Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows:
Supply Chain Finance Program Under the supply chain finance (“SCF”) program, which is administered by a third party, the Company’s vendors, at their sole discretion, are given the opportunity to sell receivables from the Company to a participating financial institution at a discount that leverages the Company’s credit profile. The commercial terms negotiated by the Company with its vendors are consistent, irrespective of whether a vendor participates in the SCF program. A participating vendor has the option to be paid by the financial institution earlier than the original invoice due date. The Company’s responsibility is limited to making payment on the terms originally negotiated by the Company with each vendor, regardless of whether the vendor sells its receivable to a financial institution. If a vendor chooses to participate in the SCF program, the Company pays the financial institution the stated amount of confirmed merchandise invoices on the stated maturity date, which is typically 60 days from the invoice date. The agreement with the financial institution does not require the Company to provide assets pledged as security or other forms of guarantees for the SCF program. As of May 3, 2025 and February 1, 2025, $43.8 million and $88.4 million of SCF program liabilities were recorded in in the Condensed Consolidated Balance Sheets, respectively. Amounts are reflected as cash used for operating activities in the Condensed Consolidated Statements of Cash Flows when settled.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BASIS OF PRESENTATION | Interim financial statements The Condensed Consolidated Financial Statements as of May 3, 2025, and for the thirteen week periods ended May 3, 2025 and May 4, 2024, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2024 filed with the SEC on March 31, 2025 (the “Fiscal 2024 Form 10-K”). The February 1, 2025 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the U.S. (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2025.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplier Finance Program | Supply Chain Finance Program Under the supply chain finance (“SCF”) program, which is administered by a third party, the Company’s vendors, at their sole discretion, are given the opportunity to sell receivables from the Company to a participating financial institution at a discount that leverages the Company’s credit profile. The commercial terms negotiated by the Company with its vendors are consistent, irrespective of whether a vendor participates in the SCF program. A participating vendor has the option to be paid by the financial institution earlier than the original invoice due date. The Company’s responsibility is limited to making payment on the terms originally negotiated by the Company with each vendor, regardless of whether the vendor sells its receivable to a financial institution. If a vendor chooses to participate in the SCF program, the Company pays the financial institution the stated amount of confirmed merchandise invoices on the stated maturity date, which is typically 60 days from the invoice date. The agreement with the financial institution does not require the Company to provide assets pledged as security or other forms of guarantees for the SCF program. As of May 3, 2025 and February 1, 2025, $43.8 million and $88.4 million of SCF program liabilities were recorded in in the Condensed Consolidated Balance Sheets, respectively. Amounts are reflected as cash used for operating activities in the Condensed Consolidated Statements of Cash Flows when settled.
|
Revenue Recognition (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of Revenue [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Text Block] | REVENUE RECOGNITION Disaggregation of revenue All revenues are recognized in net sales in the Condensed Consolidated Statements of Operations and Comprehensive Income. For information regarding the disaggregation of revenue, refer to Note 14, “SEGMENT REPORTING.” Contract liabilities The following table details certain contract liabilities representing unearned revenue as of May 3, 2025, February 1, 2025, May 4, 2024 and February 3, 2024:
(1)Includes $9.6 million and $9.9 million of revenue recognized during the thirteen weeks ended May 3, 2025 and May 4, 2024, respectively, that was included in the gift card liability at the beginning of February 1, 2025 and February 3, 2024, respectively. The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Net Income (Loss) Per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NET LOSS PER SHARE | NET INCOME PER SHARE Net income per basic and diluted share attributable to A&F is computed based on the weighted-average number of outstanding shares of A&F’s Class A Common Stock, $0.01 par value (“Common Stock”). The following table provides additional information pertaining to net income per share attributable to A&F for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1)Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieved from zero up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.
|
Fair Value |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE | FAIR VALUE Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows: •Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date. •Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly. •Level 3—inputs to the valuation methodology are unobservable. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The following table provides the three levels of the hierarchy and the distribution of the Company’s assets measured at fair value on a recurring basis, as of May 3, 2025 and February 1, 2025:
(1) Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits with original maturities of less than three months. (2) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts. (3) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies. The Company’s Level 2 assets and liabilities consisted of: •Trust-owned life insurance policies, which were valued using the cash surrender value of the life insurance policies; •Time deposits with original maturities of three months or less, which were recorded at cost, approximating fair value, due to the short-term nature of these investments; and •Derivative instruments, primarily foreign currency exchange forward contracts, which were valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The Company also holds certain investments that are not measured at fair value on a recurring basis on the Condensed Consolidated Balance Sheets, including held-to-maturity securities. Held-to-maturity securities consist primarily of time deposits with maturities less than one year, which are valued at amortized cost, approximating fair value.
|
Property and Equipment, Net |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PROPERTY AND EQUIPMENT, NET | PROPERTY AND EQUIPMENT, NET The following table provides property and equipment, net as of May 3, 2025 and February 1, 2025:
|
Leases (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lessee, Operating Leases [Text Block] | LEASES The Company is a party to leases related to its Company-operated retail stores as well as for certain of its distribution centers, office space, information technology and equipment. The following table provides a summary of the Company’s operating lease costs for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1)Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2)Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs. (3)Refer to Note 8, “ASSET IMPAIRMENT,” for details related to operating lease right-of-use asset impairment charges. The Company had minimum commitments related to operating lease contracts that have not yet commenced, primarily for certain Company-operated retail stores, of approximately $133.0 million as of May 3, 2025.
|
Asset Impairment (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset Impairment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset Impairment Charges [Text Block] | ASSET IMPAIRMENT The following table provides asset impairment charges for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Income Taxes |
3 Months Ended |
---|---|
May 03, 2025 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES The quarterly provision for income taxes is based on the current estimate of the annual effective income tax rate and the tax effect of discrete items occurring during the quarter. The Company’s quarterly provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These factors include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in laws, regulations, interpretations and administrative practices, relative changes in expenses or losses for which tax benefits are not recognized and the impact of discrete items. In addition, jurisdictions where the Company anticipates an ordinary loss for the fiscal year for which the Company does not anticipate future tax benefits are excluded from the overall computation of estimated annual effective tax rate and no tax benefits are recognized in the period related to losses in such jurisdictions. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax earnings. Impact of valuation allowances During the thirteen weeks ended May 3, 2025, the Company did not recognize income tax benefits on $10.0 million of pretax losses, primarily in Switzerland, resulting in adverse tax impacts of $1.5 million. As of May 3, 2025, the Company had foreign net deferred tax assets of approximately $41.0 million, including $9.0 million, $5.7 million, and $15.8 million in China, Japan and the United Kingdom, respectively. While the Company believes that these net deferred tax assets are more-likely-than-not to be realized, it is not a certainty, as the Company continues to evaluate and respond to situations as they emerge. Should circumstances change, the net deferred tax assets may become subject to additional valuation allowances in the future. Additional valuation allowances would result in additional tax expense. During the thirteen weeks ended May 4, 2024, the Company did not recognize income tax benefits on $7.6 million of pretax losses, primarily in Switzerland, resulting in adverse tax impacts of $1.1 million. As of February 1, 2025, there were approximately $8.2 million, $5.4 million, and $13.4 million of net deferred tax assets in China, Japan, and the United Kingdom, respectively. Share-based compensation Refer to Note 11, “SHARE-BASED COMPENSATION,” for details on income tax benefits and charges related to share-based compensation awards during the thirteen weeks ended May 3, 2025 and May 4, 2024.
|
Borrowings |
3 Months Ended |
---|---|
May 03, 2025 | |
Debt Disclosure [Abstract] | |
Borrowings | BORROWINGS ABL Facility The Amended and Restated Credit Agreement, as amended, of Abercrombie & Fitch Management Co. (“A&F Management”), a wholly-owned indirect subsidiary of A&F, provides for a senior secured asset-based revolving credit facility of up to $500 million (the “ABL Facility”), which matures on August 2, 2029. The terms of the Company’s ABL Facility have remained unchanged from those disclosed in Note 12, “BORROWINGS,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of the Fiscal 2024 Form 10-K. The Company did not have any borrowings outstanding under the ABL Facility as of May 3, 2025 or as of February 1, 2025. As of May 3, 2025, availability under the ABL Facility was $476.9 million, net of $0.4 million in outstanding stand-by letters of credit. As the Company must maintain excess availability equal to the greater of 10% of the loan cap or $36 million under the ABL Facility, borrowing capacity available to the Company under the ABL Facility was $429.2 million as of May 3, 2025. Representations, warranties and covenants The agreements related to the ABL Facility contain various representations, warranties and restrictive covenants that, among other things and subject to specified exceptions, restrict the ability of the Company and its subsidiaries to: grant or incur liens; incur, assume or guarantee additional indebtedness; sell or otherwise dispose of assets, including capital stock of subsidiaries; make investments in certain subsidiaries; pay dividends, make distributions or redeem or repurchase capital stock; change the nature of their business; and consolidate or merge with or into, or sell substantially all of the assets of the Company or A&F Management to another entity. Certain of the agreements related to the ABL Facility also contain certain affirmative covenants, including reporting requirements such as delivery of financial statements, certificates and notices of certain events, maintaining insurance and providing additional guarantees and collateral in certain circumstances. The Company was in compliance with all debt covenants under these agreements as of May 3, 2025.
|
Share-Based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHARE-BASED COMPENSATION | SHARE-BASED COMPENSATION Financial statement impact The following table provides share-based compensation expense and the related income tax impacts for the thirteen weeks ended May 3, 2025 and May 4, 2024:
The following table provides discrete income tax benefits and charges related to share-based compensation awards during the thirteen weeks ended May 3, 2025 and May 4, 2024:
The following table provides the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1) Classified within financing activities on the Condensed Consolidated Statements of Cash Flows. Restricted stock units The following table provides the summarized activity for restricted stock units for the thirteen weeks ended May 3, 2025:
(1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved from zero up to 200% of their target vesting amount. The following table provides the unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of May 3, 2025:
The following table provides additional information pertaining to restricted stock units for the thirteen weeks ended May 3, 2025 and May 4, 2024:
The following table provides the weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Derivative Instruments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DERIVATIVE INSTRUMENTS | DERIVATIVE INSTRUMENTS The Company is exposed to risks associated with changes in foreign currency exchange rates and uses derivative instruments, primarily forward contracts, to manage the financial impacts of these exposures. The Company does not use forward contracts to engage in currency speculation and does not enter into derivative financial instruments for trading purposes. The Company uses derivative instruments, primarily foreign currency exchange forward contracts designated as cash flow hedges, to hedge the foreign currency exchange rate exposure associated with forecasted foreign-currency-denominated intercompany inventory sales to foreign subsidiaries and the related settlement of the foreign-currency-denominated intercompany receivables. Fluctuations in foreign currency exchange rates will either increase or decrease the Company’s intercompany equivalent cash flows and affect the Company’s U.S. dollar earnings. Gains or losses on the foreign currency exchange forward contracts that are used to hedge these exposures are expected to partially offset this variability. Foreign currency exchange forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed upon settlement date. These foreign currency exchange forward contracts typically have a maximum term of twelve months. The sale of the inventory to the Company’s customers will result in the reclassification of related derivative gains and losses that are reported in AOCL into earnings. The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in foreign currency exchange rates result in transaction gains or losses being recorded in earnings, as GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end and upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no anticipated differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of May 3, 2025, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany transactions:
(1) Amounts reported are the U.S. dollar notional amounts outstanding as of May 3, 2025. The fair value of derivative instruments is determined using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The following table provides the location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of May 3, 2025 and February 1, 2025:
The following table provides information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1)Amount represents the change in fair value of derivative instruments. (2)Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income over the next twelve months. The following table provides additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Accumulated Other Comprehensive Loss |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCUMULATED OTHER COMPREHENSIVE LOSS | ACCUMULATED OTHER COMPREHENSIVE LOSS The following tables provide activity in AOCL for the thirteen weeks ended May 3, 2025:
(1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income. The following tables provide activity in AOCL for the thirteen weeks ended May 4, 2024:
(1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income.
|
SEGMENT REPORTING |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEGMENT REPORTING | SEGMENT REPORTING The Company’s reportable segments are based on the financial information the chief operating decision maker (“CODM”) uses to allocate resources and assess performance of its business. The Company manages its business on a geographic basis, consisting of three reportable segments: Americas; EMEA; and APAC. Corporate functions and other income and expenses are evaluated on a consolidated basis and are not allocated to the Company’s segments, and therefore are included as a reconciling item between segment and total operating income. The Americas reportable segment includes the results of operations in North America and South America. The EMEA reportable segment includes the results of operations in Europe, the Middle East and Africa. The APAC reportable segment includes the results of operations in the Asia-Pacific region, including Asia and Oceania. Intersegment sales and transfers are recorded at cost and are treated as a transfer of inventory. All intercompany revenues are eliminated in consolidation and are not reviewed when evaluating segment performance. The Company’s CODM manages business operations and evaluates the performance of each segment based on the net sales and operating income (loss) of the segment. The CODM considers actual performance relative to expectations and growth potential to determine the appropriate allocation of resources to each segment. Net sales by segment are presented by attributing revenues to a physical store location or geographical region that fulfills the order. Operating income (loss) for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributed to the segment. Corporate/other expenses include expenses incurred that are not directly attributed to a reportable segment and primarily relate to corporate or global functions such as design, sourcing, brand management, corporate strategy, information technology, finance, treasury, legal, human resources, and other corporate support services, as well as certain globally managed components of the planning, merchandising, and marketing functions. The Company reports inventories by segment as that information is used by the CODM in determining allocation of resources to the segments. The Company does not report its other assets by segment as that information is not used by the CODM in assessing segment performance or allocating resources. The following tables provide the Company’s segment information as of May 3, 2025, February 1, 2025 and May 4, 2024, and for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1)Includes the U.S., Canada, and Latin America. Net sales in the U.S. were $0.8 billion, and $0.8 billion for the thirteen weeks ended May 3, 2025 and May 4, 2024, respectively. (2)Included in selling expense on the Condensed Consolidated Statements of Operations and Comprehensive Income. (3)Other expense includes store payroll, other direct store controllable and marketing expenses included in selling expense, as well as allocated and support related expenses included in general and administrative expense on the Condensed Consolidated Statements of Operations and Comprehensive Income. (4)Corporate and other unallocated expenses represent corporate overhead expenses that have not been allocated to any segment.
The Company’s long-lived assets and intellectual property, which primarily relates to trademark assets associated with the Company’s global operations, by geographic area as of May 3, 2025, February 1, 2025 and May 4, 2024 were as follows:
(1)Includes the U.S., Canada, and Latin America. Long-lived assets and intellectual property located in the U.S. were $1.0 billion, $965 million, and $922 million as of May 3, 2025 , February 1, 2025 and May 4, 2024, respectively. (2)Includes intellectual property of $2.9 million, $2.9 million, and $2.9 million as of May 3, 2025, February 1, 2025 and May 4, 2024, respectively. (3)Includes intellectual property of $16.4 million, $16.6 million, and $17.2 million as of May 3, 2025, February 1, 2025 and May 4, 2024, respectively. Brand Information The following table provides additional disaggregated revenue information, which is categorized by brand, for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Pay vs Performance Disclosure - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
May 03, 2025 |
May 04, 2024 |
|
Pay vs Performance Disclosure | ||
Net Income (Loss) Attributable to Parent | $ 80,413 | $ 113,850 |
Insider Trading Arrangements |
3 Months Ended |
---|---|
May 03, 2025 | |
Trading Arrangements, by Individual | |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Summary of Significant Accounting Policies (Policies) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consolidation, Policy [Policy Text Block] | Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in Emirati and Kuwaiti business ventures with Majid al Futtaim Lifestyle L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of the business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive Income and the NCI portion of stockholders’ equity presented as NCI on the Condensed Consolidated Balance Sheets.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiscal Period, Policy [Policy Text Block] | Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New Accounting Pronouncements, Policy | Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. The following table provides a brief description of certain accounting pronouncements the Company has not yet adopted and that could affect the Company’s financial statements.
|
Summary of Significant Accounting Policies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] | Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. The following table provides a brief description of certain accounting pronouncements the Company has not yet adopted and that could affect the Company’s financial statements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Cash and Equivalents to Restricted cash and Equivalents [Table Text Block] | Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows:
|
Revenue Recognition (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of Revenue [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Revenue, by Arrangement, Disclosure [Table Text Block] | The following table details certain contract liabilities representing unearned revenue as of May 3, 2025, February 1, 2025, May 4, 2024 and February 3, 2024:
(1)Includes $9.6 million and $9.9 million of revenue recognized during the thirteen weeks ended May 3, 2025 and May 4, 2024, respectively, that was included in the gift card liability at the beginning of February 1, 2025 and February 3, 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of Revenue | The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Net Income (Loss) Per Share (Table) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Weighted Average Number of Shares | additional information pertaining to net income per share attributable to A&F for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1)Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieved from zero up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.
|
Fair Value (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company's Assets and Liabilities Measured at Fair Value | The following table provides the three levels of the hierarchy and the distribution of the Company’s assets measured at fair value on a recurring basis, as of May 3, 2025 and February 1, 2025:
(1) Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits with original maturities of less than three months. (2) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts. (3) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies.
|
Property and Equipment, Net (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property and Equipment, Net | property and equipment, net as of May 3, 2025 and February 1, 2025:
|
Leases (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lease, Cost [Table Text Block] | The following table provides a summary of the Company’s operating lease costs for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1)Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2)Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs. (3)Refer to Note 8, “ASSET IMPAIRMENT,” for details related to operating lease right-of-use asset impairment charges.
|
Asset Impairment (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset Impairment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Impaired Assets to be Disposed of by Method Other than Sale [Table Text Block] | asset impairment charges for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Share-Based Compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] | The following table provides share-based compensation expense and the related income tax impacts for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block] | The following table provides discrete income tax benefits and charges related to share-based compensation awards during the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee tax withheld by company for share-based compensation | The following table provides the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1) Classified within financing activities on the Condensed Consolidated Statements of Cash Flows.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restricted Stock Unit Activity | The following table provides the summarized activity for restricted stock units for the thirteen weeks ended May 3, 2025:
(1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved from zero up to 200% of their target vesting amount.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award | The following table provides the unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of May 3, 2025:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market-based restricted stock units [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions | additional information pertaining to restricted stock units for the thirteen weeks ended May 3, 2025 and May 4, 2024:
The following table provides the weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Derivative Instruments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outstanding Foreign Exchange Forward Contracts | As of May 3, 2025, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany transactions:
(1) Amounts reported are the U.S. dollar notional amounts outstanding as of May 3, 2025.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets | The fair value of derivative instruments is determined using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The following table provides the location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of May 3, 2025 and February 1, 2025:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss | information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen weeks ended May 3, 2025 and May 4, 2024:
(1)Amount represents the change in fair value of derivative instruments. (2)Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income over the next twelve months. The following table provides additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Accumulated Other Comprehensive Loss (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Loss | The following tables provide activity in AOCL for the thirteen weeks ended May 3, 2025:
(1) Amount represents gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income. The following tables provide activity in AOCL for the thirteen weeks ended May 4, 2024:
(1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income.
|
SEGMENT REPORTING (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] | The following tables provide the Company’s segment information as of May 3, 2025, February 1, 2025 and May 4, 2024, and for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Assets from Segment to Consolidated [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country | The Company’s long-lived assets and intellectual property, which primarily relates to trademark assets associated with the Company’s global operations, by geographic area as of May 3, 2025, February 1, 2025 and May 4, 2024 were as follows:
(1)Includes the U.S., Canada, and Latin America. Long-lived assets and intellectual property located in the U.S. were $1.0 billion, $965 million, and $922 million as of May 3, 2025 , February 1, 2025 and May 4, 2024, respectively. (2)Includes intellectual property of $2.9 million, $2.9 million, and $2.9 million as of May 3, 2025, February 1, 2025 and May 4, 2024, respectively. (3)Includes intellectual property of $16.4 million, $16.6 million, and $17.2 million as of May 3, 2025, February 1, 2025 and May 4, 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Sales by Brand [Table Text Block] | Brand Information The following table provides additional disaggregated revenue information, which is categorized by brand, for the thirteen weeks ended May 3, 2025 and May 4, 2024:
|
Summary of Significant Accounting Policies Condensed Consolidated Statements of Cash Flows reconciliation (Details) - USD ($) $ in Thousands |
May 03, 2025 |
Feb. 01, 2025 |
May 04, 2024 |
Feb. 03, 2024 |
---|---|---|---|---|
Condensed Statements of Cash Flows reconciliation [Abstract] | ||||
Cash and equivalents | $ 510,563 | $ 772,727 | $ 864,195 | $ 900,884 |
Restricted Cash and Cash Equivalents | 7,962 | 7,668 | 7,806 | 8,801 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $ 518,525 | $ 780,395 | $ 872,001 | $ 909,685 |
Summary of Significant Accounting Policies Supplier Chain Financing (Details) - USD ($) $ in Millions |
May 03, 2025 |
Feb. 01, 2025 |
---|---|---|
Supplier Finance Program, Obligation [Roll Forward] | ||
Supplier Finance Program, Payment Timing, Period | 60 days | |
Supplier Finance Program Obligation Current | $ 43.8 | $ 88.4 |
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration] | Accounts Payable, Current | Accounts Payable, Current |
Summary of Significant Accounting Policies Recent Accounting Pronouncements (Details) |
3 Months Ended |
---|---|
May 03, 2025 | |
Recent Accounting Pronouncements [Abstract] | |
Maximum Length Of Time Inventory Sales Hedged | 12 months |
Revenue Recognition (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
Feb. 01, 2025 |
Feb. 03, 2024 |
|||||
Gift Card | ||||||||
Deferred Revenue Arrangement [Line Items] | ||||||||
Contract with Customer, Liability, Current | $ 39,391 | $ 40,291 | $ 45,364 | [1] | $ 41,144 | [1] | ||
Contract with Customer, Liability, Revenue Recognized | 9,600 | 9,900 | ||||||
Revenue from Contract with Customer | 30,900 | 30,661 | ||||||
Royalty | ||||||||
Deferred Revenue Arrangement [Line Items] | ||||||||
Contract with Customer, Liability, Current | 33,065 | 27,546 | $ 32,199 | $ 27,937 | ||||
Revenue from Contract with Customer | $ 15,312 | $ 13,958 | ||||||
|
Net Income (Loss) Per Share (Details) - shares shares in Thousands |
3 Months Ended | |||
---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
|||
Weighted Average Shares Outstanding And Anti Dilutive Shares [Abstract] | ||||
Shares of Common Stock issued | 103,300 | 103,300 | ||
Weighted-average treasury shares | (54,086) | (52,407) | ||
Weighted-average — basic shares | 49,214 | 50,893 | ||
Dilutive effect of share-based compensation awards | 1,420 | 2,383 | ||
Weighted-average — diluted shares | 50,634 | 53,276 | ||
Anti-dilutive shares (1) | [1] | 894 | 436 | |
|
Fair Value (Assets and Liabilities at Fair Value) (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands |
May 03, 2025 |
Feb. 01, 2025 |
|||||||
---|---|---|---|---|---|---|---|---|---|
Assets, Fair Value Disclosure [Abstract] | |||||||||
Cash and Cash Equivalents, Fair Value Disclosure | [1] | $ 98,458 | $ 305,085 | ||||||
Derivative instruments (2) | [2] | 172 | 4,315 | ||||||
Restricted Investments, Noncurrent | [3] | 55,457 | 55,085 | ||||||
Restricted Cash Equivalents, Noncurrent | [1] | 4,591 | 4,566 | ||||||
Total assets | 158,678 | 369,051 | |||||||
Liabilities, Fair Value Disclosure [Abstract] | |||||||||
Derivative Liability | [2] | 8,325 | |||||||
Total liabilities | 8,325 | ||||||||
Level 1 | |||||||||
Assets, Fair Value Disclosure [Abstract] | |||||||||
Cash and Cash Equivalents, Fair Value Disclosure | [1] | 88,706 | 304,072 | ||||||
Derivative instruments (2) | [2] | 0 | 0 | ||||||
Restricted Investments, Noncurrent | [3] | 1,164 | 1,164 | ||||||
Restricted Cash Equivalents, Noncurrent | [1] | 3,078 | 3,070 | ||||||
Total assets | 92,948 | 308,306 | |||||||
Liabilities, Fair Value Disclosure [Abstract] | |||||||||
Derivative Liability | [2] | 0 | |||||||
Total liabilities | 0 | ||||||||
Level 2 | |||||||||
Assets, Fair Value Disclosure [Abstract] | |||||||||
Cash and Cash Equivalents, Fair Value Disclosure | [1] | 9,752 | 1,013 | ||||||
Derivative instruments (2) | 172 | 4,315 | [2] | ||||||
Restricted Investments, Noncurrent | [3] | 54,293 | 53,921 | ||||||
Restricted Cash Equivalents, Noncurrent | [1] | 1,513 | 1,496 | ||||||
Total assets | 65,730 | 60,745 | |||||||
Liabilities, Fair Value Disclosure [Abstract] | |||||||||
Derivative Liability | [2] | 8,325 | |||||||
Total liabilities | 8,325 | ||||||||
Level 3 | |||||||||
Assets, Fair Value Disclosure [Abstract] | |||||||||
Cash and Cash Equivalents, Fair Value Disclosure | [1] | 0 | 0 | ||||||
Derivative instruments (2) | [2] | 0 | 0 | ||||||
Restricted Investments, Noncurrent | [3] | 0 | 0 | ||||||
Restricted Cash Equivalents, Noncurrent | [1] | 0 | 0 | ||||||
Total assets | 0 | $ 0 | |||||||
Liabilities, Fair Value Disclosure [Abstract] | |||||||||
Derivative Liability | [2] | 0 | |||||||
Total liabilities | $ 0 | ||||||||
|
Property and Equipment, Net (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
May 03, 2025 |
May 04, 2024 |
Feb. 01, 2025 |
|
Property, Plant and Equipment [Line Items] | |||
Property and equipment, at cost | $ 2,686,454 | $ 2,605,871 | |
Less: Accumulated depreciation and amortization | (2,080,394) | (2,030,098) | |
Property and equipment, net | 606,060 | $ 575,773 | |
Property and equipment asset impairment | 230 | $ 527 | |
Asset Impairment Charges | $ 679 | $ 866 |
Leases (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
|||||||
Leases [Abstract] | ||||||||
Single lease cost | [1] | $ 69,847 | $ 59,980 | |||||
Variable lease cost | [2] | 48,575 | 46,169 | |||||
Operating lease right-of-use asset impairment | [3] | 449 | 339 | |||||
Sublease Income | (988) | (984) | ||||||
Operating lease cost | 117,883 | 105,504 | ||||||
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | 113,827 | 73,686 | ||||||
Cash paid for operating lease liabilities | 73,290 | $ 64,052 | ||||||
LesseeOperatingLeaseLeasesNotYetCommencedLiability | $ 133,000 | |||||||
|
Asset Impairment (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
May 03, 2025 |
May 04, 2024 |
Feb. 01, 2025 |
|
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||
Property and equipment asset impairment | $ 230 | $ 527 | |
Asset Impairment Charges | 679 | 866 | |
Operating Lease, Right-of-Use Asset | 868,130 | $ 803,121 | |
Retail Site | |||
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||
Operating Lease, Impairment Loss | 449 | $ 339 | |
Fair Value, Nonrecurring | |||
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||
Store Assets, including property and equipment and operating lease right-of-use assets | 2,600 | ||
Operating Lease, Right-of-Use Asset | $ 1,700 |
Rabbi Trust Assets (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands |
May 03, 2025 |
Feb. 01, 2025 |
||
---|---|---|---|---|
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||||
Restricted Investments, Noncurrent | [1] | $ 55,457 | $ 55,085 | |
Level 2 | ||||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||||
Restricted Investments, Noncurrent | [1] | 54,293 | 53,921 | |
Level 1 | ||||
Defined Benefit Plan, Plan Assets, Category [Line Items] | ||||
Restricted Investments, Noncurrent | [1] | $ 1,164 | $ 1,164 | |
|
Income Taxes (Details) - USD ($) |
3 Months Ended | ||
---|---|---|---|
May 03, 2025 |
May 04, 2024 |
Feb. 01, 2025 |
|
Valuation Allowance [Line Items] | |||
Pre-Tax Losses Without Tax Benefits Recognized | $ 10,000,000.0 | $ 7,600,000 | |
Valuation Allowance, Deferred Tax Asset, Increase (Decrease) Amount | 1,500,000 | 1,100,000 | |
Deferred Tax Assets, Net | 41,000,000.0 | ||
Pre-Tax Losses Without Tax Benefits Recognized | 10,000,000.0 | 7,600,000 | |
Income Tax Expense (Benefit) | 26,577,000 | $ 19,794,000 | |
CHINA | |||
Valuation Allowance [Line Items] | |||
Deferred Tax Assets, Other | 9,000,000.0 | $ 8,200,000 | |
JAPAN | |||
Valuation Allowance [Line Items] | |||
Deferred Tax Assets, Other | 5,700,000 | 5,400,000 | |
UNITED KINGDOM | |||
Valuation Allowance [Line Items] | |||
Deferred Tax Assets, Other | $ 15,800,000 | $ 13,400,000 |
Borrowings (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
May 03, 2025 |
May 04, 2024 |
|
Long-Term Borrowings [Line Items] | ||
Loss on extinguishment of debt | $ 0 | $ 168 |
Line of Credit Facility, Remaining Borrowing Capacity | 476,900 | |
Schedule of Future Payments of the Term Loan Facility | ||
ABL Facility, covenant terms, minimum remaining borrowing capacity | 429,200 | |
Letters of Credit Outstanding, Amount | (400) | |
ABL Facility | ||
Long-Term Borrowings [Line Items] | ||
Maximum borrowing capacity | $ 500,000 |
Borrowings Schedule of Short-term borrowings (Details) $ in Millions |
May 03, 2025
USD ($)
|
---|---|
Short-term debt disclosure [Abstract] | |
Line of Credit Facility, Remaining Borrowing Capacity | $ 476.9 |
Share-Based Compensation (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
May 03, 2025 |
May 04, 2024 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 34,062 | $ 65,173 |
Payment, Tax Withholding, Share-based Payment Arrangement | 34,062 | 65,173 |
Share-based compensation expense | 10,591 | 11,363 |
Tax benefit recognized related to share-based compensation expense | 1,398 | 1,278 |
Share-based Payment Arrangement, Exercise of Option, Tax Benefit | 4,591 | 14,554 |
Share-based Payment Arrangement, Cancellation of Option, Tax Charge | 0 | 0 |
Share-based Payment Arrangement, Discrete Income Tax Benefit (Charge) | 4,591 | 14,554 |
Service-based restricted stock units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total unrecognized compensation cost, net of estimated forfeitures | $ 61,175 | |
Unrecognized compensation cost, weighted-average period of recognition | 1 year 6 months | |
Total grant date fair value of awards granted | $ 31,388 | 27,256 |
Total grant date fair value of awards vested | 20,341 | 18,455 |
Performance-based restricted stock units [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total unrecognized compensation cost, net of estimated forfeitures | $ 14,876 | |
Unrecognized compensation cost, weighted-average period of recognition | 1 year | |
Total grant date fair value of awards granted | $ 7,500 | 6,483 |
Total grant date fair value of awards vested | 9,845 | 9,659 |
Market-based restricted stock units [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total unrecognized compensation cost, net of estimated forfeitures | $ 8,218 | |
Unrecognized compensation cost, weighted-average period of recognition | 1 year 2 months 12 days | |
Total grant date fair value of awards granted | $ 4,093 | 4,860 |
Total grant date fair value of awards vested | 7,214 | 7,574 |
Additional Paid-in Capital [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | $ 36,753 | $ 32,165 |
Share-Based Compensation (Restricted Stock Units Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
|||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Payment Arrangement, Exercise of Option, Tax Benefit | $ 4,591 | $ 14,554 | ||
Service-based restricted stock units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ 61,175 | |||
Restricted Stock Unit Activity, Number of Underlying Shares | ||||
Number of Underlying Shares, Beginning Balance at January 30, 2021 | 1,173,185 | |||
Number of Underlying Shares, Granted | 398,724 | |||
Number of Underlying Shares, Adjustments for performance achievement | 0 | |||
Number of Underlying Shares, Vested | (487,315) | |||
Number of Underlying Shares, Forfeited | (6,826) | |||
Number of Underlying Shares, Ending Balance at July 31, 2021 | 1,077,768 | |||
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value | ||||
Weighted-Average Grant Date Fair Value, Beginning Balance | $ 47.95 | |||
Weighted-Average Grant Date Fair Value, Granted | 78.72 | |||
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement | 0 | |||
Weighted-Average Grant Date Fair Value, Vested | 41.74 | |||
Weighted-Average Grant Date Fair Value, Forfeited | 49.13 | |||
Weighted-Average Grant Date Fair Value, Ending Balance | $ 62.20 | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 1 year 6 months | |||
Performance-based restricted stock units [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ 14,876 | |||
Restricted Stock Unit Activity, Number of Underlying Shares | ||||
Number of Underlying Shares, Beginning Balance at January 30, 2021 | 424,541 | |||
Number of Underlying Shares, Granted | 95,309 | |||
Number of Underlying Shares, Adjustments for performance achievement | 152,539 | |||
Number of Underlying Shares, Vested | (326,867) | |||
Number of Underlying Shares, Forfeited | 0 | |||
Number of Underlying Shares, Ending Balance at July 31, 2021 | [1] | 345,522 | ||
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value | ||||
Weighted-Average Grant Date Fair Value, Beginning Balance | $ 40.76 | |||
Weighted-Average Grant Date Fair Value, Granted | 78.69 | |||
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement | 30.12 | |||
Weighted-Average Grant Date Fair Value, Vested | 30.12 | |||
Weighted-Average Grant Date Fair Value, Forfeited | 0 | |||
Weighted-Average Grant Date Fair Value, Ending Balance | $ 56.59 | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 1 year | |||
Market-based restricted stock units [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ 8,218 | |||
Restricted Stock Unit Activity, Number of Underlying Shares | ||||
Number of Underlying Shares, Beginning Balance at January 30, 2021 | 212,287 | |||
Number of Underlying Shares, Granted | 47,663 | |||
Number of Underlying Shares, Adjustments for performance achievement | 87,168 | |||
Number of Underlying Shares, Vested | (174,336) | |||
Number of Underlying Shares, Forfeited | 0 | |||
Number of Underlying Shares, Ending Balance at July 31, 2021 | [1] | 172,782 | ||
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value | ||||
Weighted-Average Grant Date Fair Value, Beginning Balance | $ 58.95 | |||
Weighted-Average Grant Date Fair Value, Granted | 85.88 | $ 180.71 | ||
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement | 41.38 | |||
Weighted-Average Grant Date Fair Value, Vested | 41.38 | |||
Weighted-Average Grant Date Fair Value, Forfeited | 0 | |||
Weighted-Average Grant Date Fair Value, Ending Balance | $ 75.24 | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 1 year 2 months 12 days | |||
|
Share-Based Compensation (Restricted Stock Units Assumptions) (Details) - $ / shares |
3 Months Ended | |
---|---|---|
May 03, 2025 |
May 04, 2024 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Document Period End Date | May 03, 2025 | |
City Area Code | (614) | |
Market-based restricted stock units [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Grant date market price (in dollars per share) | $ 78.69 | $ 120.56 |
Fair value (in dollars per share) | $ 85.88 | $ 180.71 |
Price volatility | 61.00% | 59.00% |
Expected term (years) | 2 years 10 months 24 days | 2 years 10 months 24 days |
Risk-free interest rate | 3.80% | 4.30% |
Dividend yield | 0.00% | 0.00% |
Average volatility of peer companies | 45.60% | 51.80% |
Average correlation coefficient of peer companies | 0.4430 | 0.4866 |
Derivative Instruments (Outstanding Foreign Exchange Forward Contracts) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands |
May 03, 2025 |
Feb. 01, 2025 |
||
---|---|---|---|---|
Designated As Hedging Instrument | ||||
Derivative [Line Items] | ||||
Derivative Asset, Statement of Financial Position [Extensible Enumeration] | Other Assets, Current | Other Assets, Current | ||
Not Designated as Hedging Instruments | ||||
Derivative [Line Items] | ||||
Derivative Asset, Statement of Financial Position [Extensible Enumeration] | Other Assets, Current | Other Assets, Current | ||
Euro Member Countries, Euro | Designated As Hedging Instrument | ||||
Derivative [Line Items] | ||||
Notional Amount | [1] | $ 34,022 | ||
United Kingdom, Pounds | Designated As Hedging Instrument | ||||
Derivative [Line Items] | ||||
Notional Amount | [1] | 78,755 | ||
Canada, Dollars | Designated As Hedging Instrument | ||||
Derivative [Line Items] | ||||
Notional Amount | [1] | $ 90,325 | ||
|
Derivative Instruments (Derivative Fair Values on the Condensed Consolidated Balance Sheets) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands |
May 03, 2025 |
Feb. 01, 2025 |
---|---|---|
Derivatives, Fair Value [Line Items] | ||
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement | $ 172 | $ 4,315 |
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement | 8,325 | 0 |
Designated As Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement | 172 | 4,315 |
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement | $ 8,325 | $ 0 |
Derivative Asset, Statement of Financial Position [Extensible Enumeration] | Other Assets, Current | Other Assets, Current |
Derivative Liability, Statement of Financial Position [Extensible Enumeration] | Accrued Liabilities, Current | Accrued Liabilities, Current |
Not Designated as Hedging Instruments | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement | $ 0 | $ 0 |
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement | $ 0 | $ 0 |
Derivative Asset, Statement of Financial Position [Extensible Enumeration] | Other Assets, Current | Other Assets, Current |
Derivative Liability, Statement of Financial Position [Extensible Enumeration] | Accrued Liabilities, Current | Accrued Liabilities, Current |
Derivative Instruments (Derivative Gains (Losses) on the Condensed Consolidated Statement of Operations) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands |
3 Months Ended | |||||
---|---|---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
|||||
Designated As Hedging Instrument | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Amount of Gain (Loss) Reclassified from AOCL into Earnings (Effective Portion) | [1] | $ 1,600 | $ 483 | |||
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax | [2] | (11,336) | 1,029 | |||
Not Designated as Hedging Instruments | ||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||
Gain/(Loss) | $ 366 | $ 1,868 | ||||
|
Derivative Instruments (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
Feb. 01, 2025 |
||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||||
Length of time inventory sales hedged (in months) | 12 months | |||||||||
Foreign currency exchange forward contracts | Designated As Hedging Instrument | ||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||||
Derivative Instruments, Gain (Loss) Reclassified from Accumulated AOCL into Income, Effective Portion, Net | [1] | $ 1,600 | $ 483 | |||||||
Foreign currency exchange forward contracts | Euro Member Countries, Euro | Designated As Hedging Instrument | ||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||||
Notional Amount | [2] | 34,022 | ||||||||
Foreign currency exchange forward contracts | United Kingdom, Pounds | Designated As Hedging Instrument | ||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||||
Notional Amount | [2] | 78,755 | ||||||||
Foreign currency exchange forward contracts | Canada, Dollars | Designated As Hedging Instrument | ||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||||
Notional Amount | [2] | 90,325 | ||||||||
Fair Value, Recurring [Member] | ||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||||
Other current assets | [3] | 172 | $ 4,315 | |||||||
Accrued expenses | [3] | 8,325 | ||||||||
Level 2 | Fair Value, Recurring [Member] | ||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||||
Other current assets | 172 | $ 4,315 | [3] | |||||||
Accrued expenses | [3] | $ 8,325 | ||||||||
|
Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
Feb. 01, 2025 |
Feb. 03, 2024 |
|||||||
Accumulated Other Comprehensive Loss [Roll Forward] | ||||||||||
Beginning balance | $ (139,151) | |||||||||
Other comprehensive loss | (1,878) | $ (1,314) | ||||||||
Ending balance at May 3, 2025 | (141,029) | |||||||||
Total Abercrombie & Fitch Co. stockholders’ equity | 1,189,126 | $ 1,335,628 | ||||||||
Foreign Currency Translation Adjustment | ||||||||||
Accumulated Other Comprehensive Loss [Roll Forward] | ||||||||||
Other comprehensive income (loss) before reclassifications | 10,662 | (1,837) | ||||||||
Reclassified gain (loss) from AOCL | 0 | 0 | ||||||||
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent | 0 | 0 | ||||||||
Other comprehensive loss | 10,662 | (1,837) | ||||||||
Total Abercrombie & Fitch Co. stockholders’ equity | (133,221) | (138,369) | (143,883) | $ (136,532) | ||||||
Unrealized Gain (Loss) on Derivative Financial Instruments | ||||||||||
Accumulated Other Comprehensive Loss [Roll Forward] | ||||||||||
Other comprehensive income (loss) before reclassifications | (11,336) | 1,029 | ||||||||
Reclassified gain (loss) from AOCL | 1,600 | [1] | 483 | [2] | ||||||
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent | 396 | (23) | ||||||||
Other comprehensive loss | (12,540) | 523 | ||||||||
Total Abercrombie & Fitch Co. stockholders’ equity | (7,808) | 1,087 | 4,732 | 564 | ||||||
AOCI Attributable to Parent | ||||||||||
Accumulated Other Comprehensive Loss [Roll Forward] | ||||||||||
Other comprehensive income (loss) before reclassifications | (674) | (808) | ||||||||
Reclassified gain (loss) from AOCL | 1,600 | [1] | 483 | [2] | ||||||
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent | 396 | (23) | ||||||||
Other comprehensive loss | (1,878) | (1,314) | ||||||||
Total Abercrombie & Fitch Co. stockholders’ equity | $ (141,029) | $ (137,282) | $ (139,151) | $ (135,968) | ||||||
|
SEGMENT REPORTING (Segment Information, by Segment) (Details) $ in Thousands |
3 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
May 03, 2025
USD ($)
|
May 04, 2024
USD ($)
|
||||||||
Segment Reporting, Disclosure of Other Information about Entity's Reportable Segments [Abstract] | |||||||||
Segment Reporting, Factors Used to Identify Entity's Reportable Segments | The Company manages its business on a geographic basis, consisting of three reportable segments: Americas; EMEA; and APAC. Corporate functions and other income and expenses are evaluated on a consolidated basis and are not allocated to the Company’s segments, and therefore are included as a reconciling item between segment and total operating income. The Americas reportable segment includes the results of operations in North America and South America. The EMEA reportable segment includes the results of operations in Europe, the Middle East and Africa. The APAC reportable segment includes the results of operations in the Asia-Pacific region, including Asia and Oceania. Intersegment sales and transfers are recorded at cost and are treated as a transfer of inventory. All intercompany revenues are eliminated in consolidation and are not reviewed when evaluating segment performance. | ||||||||
Number of reportable segments | 3 | ||||||||
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description | The CODM considers actual performance relative to expectations and growth potential to determine the appropriate allocation of resources to each segment. | ||||||||
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] | Chief Executive Officer [Member], Chief Financial Officer [Member], Chief Operating Officer [Member] | ||||||||
Payments to Acquire Property, Plant, and Equipment | $ 50,764 | $ 38,886 | |||||||
Segment Reporting Information, Revenue for Reportable Segment [Abstract] | |||||||||
Net sales | 1,097,311 | 1,020,730 | |||||||
Segment Reporting Information, Operating Income (Loss) [Abstract] | |||||||||
Operating Income (Loss) | 101,533 | 129,849 | |||||||
Depreciation, Depletion and Amortization [Abstract] | |||||||||
Depreciation, Depletion and Amortization, Nonproduction | 38,576 | 37,689 | |||||||
Operating Segments [Member] | |||||||||
Segment Reporting, Disclosure of Other Information about Entity's Reportable Segments [Abstract] | |||||||||
Payments to Acquire Property, Plant, and Equipment | 42,089 | 25,391 | |||||||
Segment Reporting Information, Revenue for Reportable Segment [Abstract] | |||||||||
Net sales | 1,097,311 | 1,020,730 | |||||||
Segment Reporting Information, Operating Income (Loss) [Abstract] | |||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | 417,133 | 343,273 | |||||||
Store occupancy expense | 124,419 | 113,036 | [1] | ||||||
Fulfillment expense | 113,465 | 102,377 | [1] | ||||||
Segment Reporting, Other Segment Item, Amount | [2] | 203,710 | 185,518 | ||||||
Operating Income (Loss) | 238,584 | 276,526 | |||||||
Depreciation, Depletion and Amortization [Abstract] | |||||||||
Depreciation, Depletion and Amortization, Nonproduction | 30,588 | 27,131 | |||||||
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | |||||||||
Segment Reporting, Disclosure of Other Information about Entity's Reportable Segments [Abstract] | |||||||||
Payments to Acquire Property, Plant, and Equipment | 8,675 | 13,495 | |||||||
Depreciation, Depletion and Amortization [Abstract] | |||||||||
Depreciation, Depletion and Amortization, Nonproduction | 7,988 | 10,558 | |||||||
Americas [Member] | Operating Segments [Member] | |||||||||
Segment Reporting, Disclosure of Other Information about Entity's Reportable Segments [Abstract] | |||||||||
Payments to Acquire Property, Plant, and Equipment | [3] | 30,038 | 20,904 | ||||||
Segment Reporting Information, Revenue for Reportable Segment [Abstract] | |||||||||
Net sales | [3] | 874,804 | 820,121 | ||||||
Segment Reporting Information, Operating Income (Loss) [Abstract] | |||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | [3] | 329,923 | 273,499 | ||||||
Store occupancy expense | [3] | 84,920 | 78,881 | [1] | |||||
Fulfillment expense | [3] | 85,046 | 80,602 | [1] | |||||
Segment Reporting, Other Segment Item, Amount | [2],[3] | 147,955 | 134,792 | ||||||
Operating Income (Loss) | [3] | 226,960 | 252,347 | ||||||
Depreciation, Depletion and Amortization [Abstract] | |||||||||
Depreciation, Depletion and Amortization, Nonproduction | [3] | 22,955 | 19,896 | ||||||
EMEA [Member] | Operating Segments [Member] | |||||||||
Segment Reporting, Disclosure of Other Information about Entity's Reportable Segments [Abstract] | |||||||||
Payments to Acquire Property, Plant, and Equipment | 8,029 | 3,213 | |||||||
Segment Reporting Information, Revenue for Reportable Segment [Abstract] | |||||||||
Net sales | 185,036 | 164,778 | |||||||
Segment Reporting Information, Operating Income (Loss) [Abstract] | |||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | 73,597 | 57,878 | |||||||
Store occupancy expense | 28,974 | 26,632 | [1] | ||||||
Fulfillment expense | 23,486 | 17,896 | [1] | ||||||
Segment Reporting, Other Segment Item, Amount | [2] | 42,945 | 37,871 | ||||||
Operating Income (Loss) | 16,034 | 24,501 | |||||||
Depreciation, Depletion and Amortization [Abstract] | |||||||||
Depreciation, Depletion and Amortization, Nonproduction | 5,595 | 5,771 | |||||||
Asia Pacific [Member] | Operating Segments [Member] | |||||||||
Segment Reporting, Disclosure of Other Information about Entity's Reportable Segments [Abstract] | |||||||||
Payments to Acquire Property, Plant, and Equipment | 4,022 | 1,274 | |||||||
Segment Reporting Information, Revenue for Reportable Segment [Abstract] | |||||||||
Net sales | 37,471 | 35,831 | |||||||
Segment Reporting Information, Operating Income (Loss) [Abstract] | |||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | 13,613 | 11,896 | |||||||
Store occupancy expense | 10,525 | 7,523 | [1] | ||||||
Fulfillment expense | 4,933 | 3,879 | [1] | ||||||
Segment Reporting, Other Segment Item, Amount | [2] | 12,810 | 12,855 | ||||||
Operating Income (Loss) | (4,410) | (322) | |||||||
Depreciation, Depletion and Amortization [Abstract] | |||||||||
Depreciation, Depletion and Amortization, Nonproduction | $ 2,038 | $ 1,464 | |||||||
|
SEGMENT REPORTING (Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
||||||||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||||||||||
UnallocatedCorporateExpenses | [1] | $ 137,051 | $ 146,677 | ||||||||
Operating Income (Loss) | 101,533 | 129,849 | |||||||||
Interest Income (Expense), Operating | (6,783) | (5,023) | |||||||||
Income before income taxes | 108,316 | 134,872 | |||||||||
Depreciation, Depletion and Amortization, Nonproduction | 38,576 | 37,689 | |||||||||
Payments to Acquire Property, Plant, and Equipment | 50,764 | 38,886 | |||||||||
Net sales | 1,097,311 | 1,020,730 | |||||||||
Operating Segments [Member] | |||||||||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||||||||||
Operating Income (Loss) | 238,584 | 276,526 | |||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | 417,133 | 343,273 | |||||||||
Store occupancy expense | 124,419 | 113,036 | [2] | ||||||||
Fulfillment expense | 113,465 | 102,377 | [2] | ||||||||
Segment Reporting, Other Segment Item, Amount | [3] | 203,710 | 185,518 | ||||||||
Depreciation, Depletion and Amortization, Nonproduction | 30,588 | 27,131 | |||||||||
Payments to Acquire Property, Plant, and Equipment | 42,089 | 25,391 | |||||||||
Net sales | 1,097,311 | 1,020,730 | |||||||||
Operating Segments [Member] | Americas [Member] | |||||||||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||||||||||
Operating Income (Loss) | [4] | 226,960 | 252,347 | ||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | [4] | 329,923 | 273,499 | ||||||||
Store occupancy expense | [4] | 84,920 | 78,881 | [2] | |||||||
Fulfillment expense | [4] | 85,046 | 80,602 | [2] | |||||||
Segment Reporting, Other Segment Item, Amount | [3],[4] | 147,955 | 134,792 | ||||||||
Depreciation, Depletion and Amortization, Nonproduction | [4] | 22,955 | 19,896 | ||||||||
Payments to Acquire Property, Plant, and Equipment | [4] | 30,038 | 20,904 | ||||||||
Net sales | [4] | 874,804 | 820,121 | ||||||||
Operating Segments [Member] | EMEA [Member] | |||||||||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||||||||||
Operating Income (Loss) | 16,034 | 24,501 | |||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | 73,597 | 57,878 | |||||||||
Store occupancy expense | 28,974 | 26,632 | [2] | ||||||||
Fulfillment expense | 23,486 | 17,896 | [2] | ||||||||
Segment Reporting, Other Segment Item, Amount | [3] | 42,945 | 37,871 | ||||||||
Depreciation, Depletion and Amortization, Nonproduction | 5,595 | 5,771 | |||||||||
Payments to Acquire Property, Plant, and Equipment | 8,029 | 3,213 | |||||||||
Net sales | 185,036 | 164,778 | |||||||||
Operating Segments [Member] | Asia Pacific [Member] | |||||||||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||||||||||
Operating Income (Loss) | (4,410) | (322) | |||||||||
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | 13,613 | 11,896 | |||||||||
Store occupancy expense | 10,525 | 7,523 | [2] | ||||||||
Fulfillment expense | 4,933 | 3,879 | [2] | ||||||||
Segment Reporting, Other Segment Item, Amount | [3] | 12,810 | 12,855 | ||||||||
Depreciation, Depletion and Amortization, Nonproduction | 2,038 | 1,464 | |||||||||
Payments to Acquire Property, Plant, and Equipment | 4,022 | 1,274 | |||||||||
Net sales | 37,471 | 35,831 | |||||||||
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] | |||||||||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | |||||||||||
Depreciation, Depletion and Amortization, Nonproduction | 7,988 | 10,558 | |||||||||
Payments to Acquire Property, Plant, and Equipment | $ 8,675 | $ 13,495 | |||||||||
|
SEGMENT REPORTING (Reconciliation of Assets from Segment to Consolidated (Details) - USD ($) $ in Thousands |
May 03, 2025 |
Feb. 01, 2025 |
May 04, 2024 |
---|---|---|---|
Segment Reporting, Asset Reconciling Item [Line Items] | |||
Inventories | $ 542,059 | $ 575,005 | $ 449,267 |
Total assets less inventory | 2,554,117 | 2,724,882 | 2,520,818 |
Assets | 3,096,176 | 3,299,887 | 2,970,085 |
Operating Segments [Member] | Americas [Member] | |||
Segment Reporting, Asset Reconciling Item [Line Items] | |||
Inventories | 432,576 | 463,148 | 361,061 |
Operating Segments [Member] | EMEA [Member] | |||
Segment Reporting, Asset Reconciling Item [Line Items] | |||
Inventories | 86,582 | 88,728 | 70,829 |
Operating Segments [Member] | Asia Pacific [Member] | |||
Segment Reporting, Asset Reconciling Item [Line Items] | |||
Inventories | $ 22,901 | $ 23,129 | $ 17,377 |
SEGMENT REPORTING (Net Sales and Long-lived Assets) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
May 03, 2025 |
May 04, 2024 |
Feb. 01, 2025 |
|||||||||
Net Sales | $ 1,097,311 | $ 1,020,730 | |||||||||
Long-Lived Assets | 1,493,433 | 1,260,270 | $ 1,398,346 | ||||||||
Inventory, Net | 542,059 | 449,267 | 575,005 | ||||||||
Total assets less inventory | 2,554,117 | 2,520,818 | 2,724,882 | ||||||||
Assets | 3,096,176 | 2,970,085 | 3,299,887 | ||||||||
Operating Segments [Member] | |||||||||||
Net Sales | 1,097,311 | 1,020,730 | |||||||||
United States | |||||||||||
Net Sales | 800,000 | 800,000 | |||||||||
Long-Lived Assets | 1,000,000 | 922,000 | 965,000 | ||||||||
Americas [Member] | |||||||||||
Long-Lived Assets | [1],[2] | 1,044,664 | 948,526 | 991,673 | |||||||
Finite-Lived Intangible Assets, Net | 2,900 | 2,900 | 2,900 | ||||||||
Americas [Member] | Operating Segments [Member] | |||||||||||
Net Sales | [3] | 874,804 | 820,121 | ||||||||
Inventory, Net | 432,576 | 361,061 | 463,148 | ||||||||
EMEA [Member] | |||||||||||
Long-Lived Assets | [4] | 324,531 | 261,853 | 292,285 | |||||||
Finite-Lived Intangible Assets, Net | 16,400 | 17,200 | 16,600 | ||||||||
EMEA [Member] | Operating Segments [Member] | |||||||||||
Net Sales | 185,036 | 164,778 | |||||||||
Inventory, Net | 86,582 | 70,829 | 88,728 | ||||||||
Asia Pacific [Member] | |||||||||||
Long-Lived Assets | 124,238 | 49,891 | 114,388 | ||||||||
Asia Pacific [Member] | Operating Segments [Member] | |||||||||||
Net Sales | 37,471 | 35,831 | |||||||||
Inventory, Net | $ 22,901 | $ 17,377 | $ 23,129 | ||||||||
|
SEGMENT REPORTING (Net Sales by Brand) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
May 03, 2025 |
May 04, 2024 |
|
Schedule of Revenue by Brand [Line Items] | ||
Net Sales | $ 1,097,311 | $ 1,020,730 |
Abercrombie [Member] | ||
Schedule of Revenue by Brand [Line Items] | ||
Net Sales | 547,947 | 571,513 |
Hollister [Member] | ||
Schedule of Revenue by Brand [Line Items] | ||
Net Sales | $ 549,364 | $ 449,217 |
>#BJN8:+L[;V9;/9
M)S-=1ZG4'<&1:B#Z&BX=OQ/>V.) WAQQ<4%N9(HDR1\H,^,H]/*/^GY"!B[!
M9C[1OGV(,(>/F+ +0% I0$DJQ70;M,!RE4Z+Z/S2BS\MSP68$3WKT#M\]P3;
MQ'[JXX3,_Y&>V2=4&8WC9 S!^322R!4T:J!J'WH? 1G!AF#73<^./=U+MUNF
M62Y8O_QS4Z\FP*Z1&S2'LT%12NTJSV*/NN==3?/@I^Q\ 4;N0'*)RD@.Z'D>
M8/XQHH#U_G78BX(/57I!-9C]=;9Q21B<@RA)70ER& A![]/(_2E+_ZFT%%6Z1;'T=Q2,
M=[@7=3J+D$DP$^#)"D">P_6EH&]U3'Z1J0>63?(VN@G*XTU@TV9QY']&\4_&
M_E+^B"T ,%0@J%.?TZI&<38PYU36+BN.[)J
MJC4_ISA5AS.&T-J:64>FB%MRKE0E>'%!RYC:2CV*6I"JP6&P!9L-I NM,565
M@MYGVUS.^= 0\<<[P$-86,.LR)W._@>8*&*NC916,FW.=D (XDYJ*@] ($%E
M]:&R3).(@U!9EI"T5K=C&:>GHKI@]ZDJ51J.22EIK -6/;DLMVT,F$LA5M]6
MUL[N99U9FZN&LLZNZV@7&_B=12JB;S !?[#A'-G:#L+2>;>#J(%)?8[4MJ^Z
M(!#VM4<^AZ)Z @WC+?_Z(C-'9M>1C'Y,Y3<<1SC
MT'V5TI@\+*"%A"3D_6NN<7K3?T O9>&912O_6M;V1:FX"1D)V>%3
M=K8K3/I>M[Z#2Q$<:)';!7W#19>V@P7(^(,/7\E=3ZSS<]\/4>B2!TI^F*3Q
MN"+8<(S1CNW*9V^@-LY1,K@,HN??L?>(?T-^2 _*]U,
NO&
@@JT
M1-X49%*,88T;>)\@H=.34(%268F$MNN8G3-TO%X\^13HF+PE$,*'FK)A9I&I
MA:ORV"KILLRZ?W;I)Q=O.Y;63=?B$7OPMMWJZK)BU;LIO?! '$0_Y4=%#EHY
MIEIO$%!!10=144M2T58UM2/"*6=(0J755&Z"J*.VNH9L.FI-J.AL47]I043L
M%#T8^.8Y)"NH)OV 8.U41":AY/?Q^:C7I9I]Q>-DEL:ZJ9(WB>15A6-<#@ZLEW#>^P^.
M"M3+$';%&X)HAXG28CZZE0.P(_!+ G(?'C,$)=4/0CHLT#KC/V-]F\1%@+30
M(;&;9@$J7S^E_\#
S,"'-T_]"(>0?3X^GDQ?\/%>:@;A
MC/039 <_N(A]"3#.+^?GDUJ5,MYL1:@@8NGBS2;![B@89L/4=62;,KO\09R
MR>[.@(1P*:4Z-Y3Z;CB2AF/_51J!6"",..BOC#:VTN&"/C*DC/?!HR.&)8&/
MN$H> 3)ZZL/112^FV1W]A$>F/]"T"8!6P)BA=)2\/YSW0F_@P6QCXL?!46,!
M$2E(%(VI-S^FW KOA&$26%R0^4#CG\;S?L1D2BDN?/7&8XEX6*( E_?AO 9^
M J%4XC]'BVWDCK^K??AZNO)?^?P]C$.?;$3;(+N<$CZ4>X3?F\_M8%]P$@)
M).(&V#47!O^K"\2!;P=1CE3C3PMV,(=Q1VXD@57*0$#2A)"6!?0*LD@3]*69
M"^J<.QZC8WT(FX%H'Z'T S;+[5'?71M5J=*C",@,WH)+XKX$A##&1YF2W(+3
M6CP(=MR?H@-J#O>_+7H$I[]W0